Latest Legal Proceedings News

Epsilon Healthcare reported a 19% revenue increase to $3.4 million for the half year ended June 2025, driven by new client wins and its pharmacy segment launch. However, net losses widened 44% to $2.07 million, reflecting administration and financing costs during its recovery phase.

Fiducian Group’s subsidiary Fiducian Investment Management Services Limited has filed a defence after ASIC initiated civil proceedings alleging misleading disclosure and compliance failures related to a managed fund.

Xstate Resources has launched a prospectus offering nearly 97 million free attaching options to placement participants and contractors, alongside a nominal cleansing offer to remove trading restrictions on recent share issuances.

Korab Resources reports significant gold and base metals exploration progress at its Rum Jungle Project, alongside innovative mining method evaluations and ongoing legal challenges to key lease renewals.

Dateline Resources reaffirms its Colosseum Gold-REE Project metrics and economics while navigating ongoing legal proceedings involving its CEO and rare earth tenements in the US.

US1 Critical Minerals and Apex USA Resources have intensified their legal dispute with Stephen Baghdadi and Dateline Resources over rare earth tenements in California, with a Federal Court hearing scheduled for later this month.

Dexus launches the Dexus Strategic Investment Trust series, acquiring a 25% stake in Westfield Chermside and raising $390 million for its DREP2 fund, while legal mediation is pushed to March 2026.

Triangle Energy has launched legal proceedings against Echelon Energy's subsidiary over a $3.84 million cost dispute tied to a farm-in agreement in the Perth Basin. The move follows failed negotiations after Echelon's withdrawal from drilling obligations.

Holista Colltech has received a formal notice from ASIC seeking recovery of approximately $1.09 million in legal costs related to Federal Court proceedings. The company is currently reviewing its options amid ongoing regulatory scrutiny.

Mayne Pharma has rejected Cosette Pharmaceuticals’ notice to terminate their merger agreement, citing Cosette’s failure to meet obligations that led to regulatory approval issues. The dispute raises fresh uncertainty over the proposed acquisition’s future.

Kula Gold Limited’s board unanimously recommends shareholders accept Forrestania Resources’ off-market takeover offer, valuing Kula shares at a significant premium and promising reduced funding risks and exposure to a stronger combined gold portfolio.

MEC Resources Ltd has announced a placement of over 359 million new options to raise approximately $359,000, with directors participating to offset fees. The offer comes as the company navigates ongoing legal challenges related to its key PEP-11 permit.